# Effect of Metformin as Add-on Therapy in Levodopa Treated Parkinson's Disease Patients

> **NCT07055958** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh** · enrollment: 74 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Metformin
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT07055958
- **Lead sponsor:** Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-12-29
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-07-20
- **Target enrollment:** 74 (ESTIMATED)
- **Last updated:** 2025-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07055958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07055958, "Effect of Metformin as Add-on Therapy in Levodopa Treated Parkinson's Disease Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07055958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*